manufacturing problems — e.g. “Disruption of the manufacture of the drug.” (Canada)
Recent shortage history
Italy: resolved 15 Sept 2026 (began 15 Sept 2026)
Australia: resolved 26 Jun 2026 (began 29 May 2026)
Australia: resolved 8 May 2026 (began 8 May 2026)
Italy: resolved 15 Apr 2026 (began 15 Apr 2026)
Italy: resolved 18 Nov 2025 (began 18 Nov 2025)
Australia: resolved 23 Mar 2026 (began 1 Sept 2025)
New Zealand: resolved 13 Aug 2025 (began 13 Aug 2025)
Italy: resolved 1 Apr 2022 (began 1 Apr 2022)
Frequently asked questions
Is Raloxifene-Hydrochloride currently in shortage?
Yes. As of the latest regulator updates, Raloxifene-Hydrochloride has 1 active shortage notice across 1 country (Canada). Status is refreshed daily from official regulatory sources.
Why is Raloxifene-Hydrochloride in shortage?
Regulators attribute the current Raloxifene-Hydrochloride shortages to manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Raloxifene-Hydrochloride shortage be resolved?
Regulator-estimated resolution dates currently range from 21 Aug 2026 to 21 Aug 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Raloxifene-Hydrochloride shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Raloxifene-Hydrochloride status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.